Nephrol Dial Transplant (1993) 8: 235-239
© 1993 European Renal Association-European Dialysis and Transplant Association
research-article
Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients
1Unit for Renal and Infectious Diseases, Algemeen Ziekenhuis Sint Jan Brugge, Belgium 2Department of Microbiology, Algemeen Ziekenhuis Sint Jan Brugge, Belgium 3Institut Pasteur du Brabant Bruxelles, Belgium 4Division of General Medicine, Clinical Epidemiology and Health Services Research, University of Iowa Hospitals and Clinics Iowa City, Iowa, USA
Correspondence and offprint requests to: Correspondence and offprint requests to: Dr J. R. Boelaert, Unit for Renal and Infectious Diseases, Algemeen Ziekenhuis Sint-Jan, B-8000 Brugge, Belgium
The incidence of S. aureus bacteraemia in a haemodialysis unit was studied over 2 years (167.75 patient-years of follow-up) during which nasal calcium mupirocin was used to eradicate nasal S. aureus carriage; this incidence was compared to that previously observed in the same unit before the use of nasal mupirocin (185.8 patient-years). Nasal mupirocin led to eradication of nasal S. aureus carriage in 96.3% of surveillance cultures and to a fourfold reduction in the incidence of S. aureus bacteraemia per patient-year, from 0.097 before mupirocin to 0.024 with mupirocin use (P=0.008). Once or thrice weekly maintenance regimens of mupirocin were equally efficacious. The incidence of bacteraemia caused by other microorganisms was not significantly affected. One single mupirocin-resistant isolate was identified in a nasal surveillance culture. Eradication of S. aureus from the nares did not lead to overgrowth by other microorganisms. Chemoprophylaxis with nasal mupirocin in haemodialysis patients is cost-effective.
Keywords: bacteraemia; haemodialysis; infection; mupirocin; nasal carriage; Staphylococcus aureus
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. A. Noskin, R. J. Rubin, J. J. Schentag, J. Kluytmans, E. C. Hedblom, M. Smulders, E. Lapetina, and E. Gemmen The Burden of Staphylococcus aureus Infections on Hospitals in the United States: An Analysis of the 2000 and 2001 Nationwide Inpatient Sample Database Arch Intern Med, August 8, 2005; 165(15): 1756 - 1761. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hoen Infective endocarditis: a frequent disease in dialysis patients Nephrol. Dial. Transplant., June 1, 2004; 19(6): 1360 - 1362. [Full Text] [PDF] |
||||
![]() |
S. J. Peacock, A. Justice, D. Griffiths, G. D. I. de Silva, M. N. Kantzanou, D. Crook, K. Sleeman, and N. P. J. Day Determinants of Acquisition and Carriage of Staphylococcus aureus in Infancy J. Clin. Microbiol., December 1, 2003; 41(12): 5718 - 5725. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Schild, S. Simon, J. Prieto, and J. Raines Single-Center Review of Infections Associated with 1,574 Consecutive Vascular Access Procedures Vascular and Endovascular Surgery, January 1, 2003; 37(1): 27 - 31. [Abstract] [PDF] |
||||
![]() |
C. E. Lok, K. E. Stanley, J. E. Hux, R. Richardson, S. W. Tobe, and J. Conly Hemodialysis Infection Prevention with Polysporin Ointment J. Am. Soc. Nephrol., January 1, 2003; 14(1): 169 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Johnson, R. MacGinley, T. D. Kay, C. M. Hawley, S. B. Campbell, N. M. Isbel, and P. Hollett A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters Nephrol. Dial. Transplant., October 1, 2002; 17(10): 1802 - 1807. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Mickley Central venous catheters: many questions, few answers Nephrol. Dial. Transplant., August 1, 2002; 17(8): 1368 - 1373. [Full Text] [PDF] |
||||
![]() |
G. K. Dogra, H. Herson, B. Hutchison, A. B. Irish, C. H. Heath, C. Golledge, G. Luxton, and H. Moody Prevention of Tunneled Hemodialysis Catheter-Related Infections Using Catheter-Restricted Filling with Gentamicin and Citrate: A Randomized Controlled Study J. Am. Soc. Nephrol., August 1, 2002; 13(8): 2133 - 2139. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Perl, J. J. Cullen, R. P. Wenzel, M. B. Zimmerman, M. A. Pfaller, D. Sheppard, J. Twombley, P. P. French, L. A. Herwaldt, and the Mupirocin and the Risk of Staphylococcus aureu Intranasal Mupirocin to Prevent Postoperative Staphylococcus aureus Infections N. Engl. J. Med., June 13, 2002; 346(24): 1871 - 1877. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.J. Peacock, S. Mandal, and I.C.J.W. Bowler Preventing Staphylococcus aureus infection in the renal unit QJM, June 1, 2002; 95(6): 405 - 410. [Full Text] [PDF] |
||||
![]() |
C. von Eiff, K. Becker, K. Machka, H. Stammer, and G. Peters Nasal Carriage as a Source of Staphylococcus aureus Bacteremia N. Engl. J. Med., January 4, 2001; 344(1): 11 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Kiser, J. M. Cantey-Kiser, and J. C. Lee Development and Characterization of a Staphylococcus aureus Nasal Colonization Model in Mice Infect. Immun., October 1, 1999; 67(10): 5001 - 5006. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Nguyen, C. A. Kauffman, R. P. Goodman, C. Squier, R. D. Arbeit, N. Singh, M. M. Wagener, and V. L. Yu Nasal Carriage of and Infection with Staphylococcus aureus in HIV-Infected Patients Ann Intern Med, February 2, 1999; 130(3): 221 - 225. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ruef, S. Fanconi, and D. Nadal STERNAL WOUND INFECTION AFTER HEART OPERATIONS IN PEDIATRIC PATIENTS ASSOCIATED WITH NASAL CARRIAGE OF STAPHYLOCOCCUS AUREUS J. Thorac. Cardiovasc. Surg., September 1, 1996; 112(3): 681 - 686. [Abstract] [Full Text] |
||||









